SPY hits new highs, but downside risk grows amid the Iran war, narrow breadth, Fed uncertainty, and hyperscaler earnings.

Management described Q1 as a continuation of margin and operating leverage progress, pairing reaffirmed 2026 pretax pre-provision income growth of 20% to 25% with expectations for steady NIM expansion ...

Q4 FY2026 earnings call recap: revenue, margins, profitability, Peiyou expansion, AI learning devices & FY2027 outlook—read key takeaways now.

"Our guidance range for NAREIT FFO is now $3.05 to $3.15 per share" and "2026 FFO guidance range, absent these advisory costs is $3.09 to $3.19 per share, which is unchanged compared to our last call" ...

Iran continues to demand that ships receive its permission to cross the strait, while President Donald Trump claimed on ...

Q1 2026 Earnings Call April 23, 2026 1:00 PM EDTCompany ParticipantsAnn DeVries - Senior VP of Strategic Finance & ...

Carriage Services stock stays a "Buy" as revenue, profits, and cash flow rise. Here's what investors need to know about CSV.

Against what could already be considered a conservative consensus, especially for revenues, for the last three consecutive ...

The next earnings report from Alphabet (GOOGL) is due on April 29, 2026, with expectations running high. One of the main ...

Q1 organic volume +2.8% beat expectations as premium mix boosted profits. Guidance reaffirmed, €750m buyback and higher ...

Nasdaq, Inc. ( NDAQ) Q1 2026 Earnings Call April 23, 2026 8:00 AM EDT Good day, and thank you for standing by. Welcome to Nasdaq's First Quarter 2026 Results Conference Call. [Operator Instructions] ...

SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.